Tag: Aravive

November 12, 2019

Aravive and AstreZeneca Begin Phase 1/2 Study of AVB-500

The Phase 1/2 clinical trial of AVB-500 is being done in combination with durvalumab in patients with ovarian cancer.
September 27, 2019

Aravive Presents Positive Phase 1b Portion of Phase 1b/2 Study

The company presented the data in an oral presentation at the European Society for Medical Oncology Congress in Barcelona.
September 22, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Lexicon Soars

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
August 4, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Exicure Leads

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...